Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Anti-nausea pill's effect on weight-loss drug tested in 59 adults

NCT ID NCT07310563

First seen Jan 06, 2026 · Last updated May 17, 2026 · Updated 16 times

Summary

This study looked at whether taking an anti-nausea medication (ondansetron) changes the amount of AMG 133 in the blood of people who are overweight or obese. 59 adults took AMG 133 alone or with the anti-nausea drug. The goal was to measure drug levels and check for side effects, not to treat obesity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CenExel Collaborative Neuroscience Research, LLC Los Alamitos

    Los Alamitos, California, 90720, United States

Conditions

Explore the condition pages connected to this study.